TY - JOUR
T1 - Importance of obtaining remission for work productivity and activity of patients with rheumatoid arthritis
AU - Kim, Dam
AU - Kaneko, Yuko
AU - Takeuchi, Tsutomu
N1 - Funding Information:
From the Division of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan. YK has received consultancies, speaking fees, and/or honoraria from AbbVie Inc., Chugai Pharmaceutical Co. Ltd., and Mitsubishi Tanabe Pharma Co. TT has received consultancies, speaking fees, and/or honoraria from Astellas Pharma, Bristol–Myers K.K., Chugai Pharmaceutical Co. Ltd., Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., Mitsubishi Tanabe Pharma Co., Pfizer Japan Inc., Santen Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd., Teijin Pharma Ltd., AbbVie GK, Asahikasei Pharma Corp., Taisho Toyama Pharmaceutical Co. Ltd., SymBio Pharmaceuticals Ltd., Janssen Pharmaceutical K.K., Takeda Pharmaceutical Co. Ltd, Nipponkayaku Co. Ltd, Astra Zeneca K.K., Eli Lilly Japan K.K., and Novartis Pharma K.K. D. Kim, MD, PhD, Division of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, and Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine; Y. Kaneko, MD, PhD, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine; T. Takeuchi, MD, PhD, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine. Address correspondence to Dr. Y. Kaneko, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan. E-mail: ykaneko@z6.keio.jp Accepted for publication April 11, 2017.
Publisher Copyright:
© The Journal of Rheumatology 2017.
PY - 2017/8/1
Y1 - 2017/8/1
N2 - Objective. To identify the factors relevant to work and activity impairment in patients with rheumatoid arthritis. Methods. In total, 1274 consecutive patients were included. Work and activity impairment were measured by the Work Productivity and Activity Impairment questionnaire, and related clinical factors were examined. Results. Work and activity impairment was reported by 67.4% of the patients. Multivariable linear regression analyses revealed pain and non-remission to be associated with activity impairment and presenteeism. Patients in remission had significantly less activity impairment and presenteeism than those with low disease activity. Conclusion. Remission achievement is essential for ensuring work performance and activity.
AB - Objective. To identify the factors relevant to work and activity impairment in patients with rheumatoid arthritis. Methods. In total, 1274 consecutive patients were included. Work and activity impairment were measured by the Work Productivity and Activity Impairment questionnaire, and related clinical factors were examined. Results. Work and activity impairment was reported by 67.4% of the patients. Multivariable linear regression analyses revealed pain and non-remission to be associated with activity impairment and presenteeism. Patients in remission had significantly less activity impairment and presenteeism than those with low disease activity. Conclusion. Remission achievement is essential for ensuring work performance and activity.
UR - http://www.scopus.com/inward/record.url?scp=85027859921&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85027859921&partnerID=8YFLogxK
U2 - 10.3899/jrheum.161404
DO - 10.3899/jrheum.161404
M3 - Article
C2 - 28507184
AN - SCOPUS:85027859921
SN - 0315-162X
VL - 44
SP - 1112
EP - 1117
JO - Journal of Rheumatology
JF - Journal of Rheumatology
IS - 8
ER -